Johnson & Johnson Considers Major Orthopedic Business Split

Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!

Kenvue's Remarkable Rebound: Shaking Off White House Pressure and Soaring Back

Kenvue's Rollercoaster: How Tylenol Maker's Shares Defied Trump's Autism Claims

Kenvue's Remarkable Ascent: From Record Lows to Market Momentum

Kenvue Stock Plummets Amid Tylenol Autism Lawsuit & Trump's Fiery Call to Arms

Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead

Tylenol Under Fire? Kenvue Shares Plummet Amid Rumors of Trump's Autism Link Announcement

Trump's Autism Comments Ignite Market Volatility for Tylenol Maker Kenvue

Shockwaves Expected as Trump Administration Weighs Linking Common Painkiller Tylenol to Autism and ADHD, Considering Urgent Warnings for Pregnant Women

Tylenol Under Scrutiny: Autism Link Fears Rock Kenvue & J&J Shares

Kenvue Explores 'Learned Intermediary' Defense Amidst Thousands of Tylenol-Autism Lawsuits

Kenvue's Tylenol Turmoil: RFK Jr.'s Autism Report Sends Stock Reeling Amidst Scientific and Legal Battles

Tylenol Under Scrutiny: Kenvue Stock Hits Year-Low Amid Reports of Autism Link Warning for Pregnancy Use

RFK Jr.'s Tylenol Claims Send Ripples Through Kenvue Stock Amidst Autism Debate